$ACT Company News
Post# of 74550
Posted On: 05/15/2014 11:51:15 AM
$ACT Company News
Pfizer's plan to relocate after merger deal draws lawmakers' fire
11:30 a.m. May 9, 2014
- blogs.marketwatch.com
Corner drug store may move overseas to save on taxes
6:30 a.m. April 16, 2014
- Al Lewis
Intuitive Surgical slumps; Facebook extends rally
3:41 p.m. April 9, 2014
- Saumya Vaishampayan
Actavis acquires Silom Medical for $100 million
10:19 a.m. April 1, 2014
- MarketWatch.com
The 10 most overbought stocks in the S&P 500 index
12:19 p.m. March 25, 2014
- The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares
1:33 p.m. March 14, 2014
- blogs.marketwatch.com
Mylan to start selling generic Celebrex in May
7:22 a.m. March 13, 2014
- MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted
3:21 p.m. March 12, 2014
- blogs.marketwatch.com
Staples awash in red; eBay up as Icahn posts new letter
4:09 p.m. March 6, 2014
- Victor Reklaitis
Icahn Enterprises reports profit up 144% in 2013
10:22 a.m. March 3, 2014
- MarketWatch
Citadel hedge fund’s recent moves
11:12 a.m. Feb. 25, 2014
- Insider Monkey
Stocks rally; S&P 500 ends right below record
4:45 p.m. Feb. 24, 2014
- Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave
5:31 a.m. Feb. 24, 2014
- Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings
11:21 a.m. Feb. 20, 2014
- blogs.marketwatch.com
Actavis swings to loss on charges, write-downs
8:03 a.m. Feb. 20, 2014
- MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says
1:59 p.m. Feb. 19, 2014
- blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal
11:03 a.m. Feb. 19, 2014
- blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row
4:38 p.m. Feb. 18, 2014
- Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal
4:10 p.m. Feb. 18, 2014
- Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap
4:06 p.m. Feb. 18, 2014
- blogs.marketwatch.com
Actavis extends marketing agreement
9:32 a.m. Today9:32 a.m. May 15, 2014
- Seeking Alpha
Lilly loses Alimta patent case in U.K. to Actavis
8:56 a.m. Today8:56 a.m. May 15, 2014
- Seeking Alpha
Lilly Says Court Rules in Favor of Generic Maker on Alimta
6:44 a.m. Today6:44 a.m. May 15, 2014
- The Wall Street Journal Interactive Edition
New leadership team at Actavis after Forest deal closes
9:56 a.m. May 14, 2014
- Seeking Alpha
Forest Labs' Saunders to Head Actavis When Deal Closes
8:55 a.m. May 14, 2014
- The Wall Street Journal Interactive Edition
Cross-Border Megamergers Drive Global Takeover Boom
4:01 p.m. May 12, 2014
- Investors Business Daily
3 Drugs Stocks On The Rise
1:02 p.m. May 12, 2014
- TheStreet.com
Actavis and Valeant settle patent fight
8:26 a.m. May 12, 2014
- Seeking Alpha
The 'Inversion' Premium
7:29 p.m. May 11, 2014
- The Wall Street Journal Interactive Edition
Vivus Discloses Competitive Threat
10:51 a.m. May 10, 2014
- Seeking Alpha
M.D. Sass: Bullish on Broadcast, Health Care
3:26 a.m. May 10, 2014
- Barrons.com
Acorda Misses on Earnings, Beats Revs - Analyst Blog
1:43 p.m. May 7, 2014
- Zacks.com
3 Drugs Stocks Dragging The Industry Down
1:03 p.m. May 7, 2014
- TheStreet.com
What Does Celgene's May 15 Markman Hearing Mean to You?
10:11 a.m. May 7, 2014
- TheStreet.com
Actavis, Michael Kors Among World Stocks Near Buy Points
5:50 p.m. May 6, 2014
- Investors Business Daily
10-Q: ACTAVIS PLC
5:15 p.m. May 5, 2014
- Edgar Online - (EDG = 10Q, 10K)
Hottest Healthcare Stocks Now – HMSY ACAD ACT MWIV
1:45 p.m. May 5, 2014
- InvestorPlace.com
Best Five Stocks Over $100
10:07 a.m. May 3, 2014
- 247WallSt.com
AstraZeneca Nixes New Bid As Pfizer Woos British PM
1:11 p.m. May 2, 2014
- Investors Business Daily
Earnings Beat at Endo, Shares Up on Improved Outlook - Analyst Blog
12:10 p.m. May 2, 2014
- Zacks.com
Actavis Extends Exclusive Agreement to Distribute Authorized Generic Concerta®
8:45 a.m. Today8:45 a.m. May 15, 2014
- PR Newswire - PRF
Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Forest Laboratories Acquisition
8:00 a.m. May 14, 2014
- PR Newswire - PRF
Agreements, Earnings Releases, Senior-Level Retirements and Appointments, and Marketing Authorizations - Analyst Notes on Actavis, Jazz Pharmaceuticals, Bristol-Myers, Biogen Idec and AbbVie
7:00 a.m. May 14, 2014
- PR Newswire - PRF
Actavis Receives Final Approval for Generic Version of Exalgo®
5:00 p.m. May 13, 2014
- PR Newswire - PRF
Actavis to Present at Sanford C. Bernstein Thirtieth Annual Strategic Decisions Conference 2014
4:45 p.m. May 13, 2014
- PR Newswire - PRF
Actavis Announces Acanya® Gel Patent Challenge Settlement
8:00 a.m. May 12, 2014
- PR Newswire - PRF
Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn
11:30 a.m. May 9, 2014
- PR Newswire - PRF
Actavis Launches Generic Version of Catapres-TTS®
4:05 p.m. May 7, 2014
- PR Newswire - PRF
Financial Results, Study Results, and Conference Schedules - Analyst Notes on Actavis, BMS, Baxter, Biogen Idec and AbbVie
9:00 a.m. May 6, 2014
- PR Newswire - PRF
Actavis and Forest Announce Effectiveness of Registration Statement
on Form S-4
9:02 a.m. May 5, 2014
- BusinessWire - BZX
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4
9:00 a.m. May 5, 2014
- PR Newswire - PRF
Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline
and Drop Tax Rate, an Industrial Info News Alert
6:31 a.m. April 30, 2014
- Marketwire
Stocks Close to Reporting their Earnings -- Research on Actavis, NYSE Community Bancorp, Hess, and Dominion Resources
4:36 a.m. April 30, 2014
- PR Newswire - PRF
Actavis Sues FDA Regarding Delay of Generic Celebrex® Approval
5:14 p.m. April 28, 2014
- PR Newswire - PRF
Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard
8:00 a.m. April 28, 2014
- PR Newswire - PRF
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts
8:00 a.m. April 25, 2014
- PR Newswire - PRF
Actavis Announces Celebrex® Patent Challenge Settlement
9:20 a.m. April 24, 2014
- PR Newswire - PRF
Actavis Announces Departure of G. Frederick Wilkinson, President, Actavis Global R&D
9:03 a.m. April 21, 2014
- PR Newswire - PRF
Actavis to Acquire Four Products from Akorn
4:15 p.m. April 17, 2014
- PR Newswire - PRF
Actavis and Forest Laboratories Receive FTC Second Request Under Hart-Scott-Rodino
4:05 p.m. April 17, 2014
- PR Newswire - PRF
Pfizer's plan to relocate after merger deal draws lawmakers' fire
11:30 a.m. May 9, 2014
- blogs.marketwatch.com
Corner drug store may move overseas to save on taxes
6:30 a.m. April 16, 2014
- Al Lewis
Intuitive Surgical slumps; Facebook extends rally
3:41 p.m. April 9, 2014
- Saumya Vaishampayan
Actavis acquires Silom Medical for $100 million
10:19 a.m. April 1, 2014
- MarketWatch.com
The 10 most overbought stocks in the S&P 500 index
12:19 p.m. March 25, 2014
- The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares
1:33 p.m. March 14, 2014
- blogs.marketwatch.com
Mylan to start selling generic Celebrex in May
7:22 a.m. March 13, 2014
- MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted
3:21 p.m. March 12, 2014
- blogs.marketwatch.com
Staples awash in red; eBay up as Icahn posts new letter
4:09 p.m. March 6, 2014
- Victor Reklaitis
Icahn Enterprises reports profit up 144% in 2013
10:22 a.m. March 3, 2014
- MarketWatch
Citadel hedge fund’s recent moves
11:12 a.m. Feb. 25, 2014
- Insider Monkey
Stocks rally; S&P 500 ends right below record
4:45 p.m. Feb. 24, 2014
- Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave
5:31 a.m. Feb. 24, 2014
- Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings
11:21 a.m. Feb. 20, 2014
- blogs.marketwatch.com
Actavis swings to loss on charges, write-downs
8:03 a.m. Feb. 20, 2014
- MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says
1:59 p.m. Feb. 19, 2014
- blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal
11:03 a.m. Feb. 19, 2014
- blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row
4:38 p.m. Feb. 18, 2014
- Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal
4:10 p.m. Feb. 18, 2014
- Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap
4:06 p.m. Feb. 18, 2014
- blogs.marketwatch.com
Actavis extends marketing agreement
9:32 a.m. Today9:32 a.m. May 15, 2014
- Seeking Alpha
Lilly loses Alimta patent case in U.K. to Actavis
8:56 a.m. Today8:56 a.m. May 15, 2014
- Seeking Alpha
Lilly Says Court Rules in Favor of Generic Maker on Alimta
6:44 a.m. Today6:44 a.m. May 15, 2014
- The Wall Street Journal Interactive Edition
New leadership team at Actavis after Forest deal closes
9:56 a.m. May 14, 2014
- Seeking Alpha
Forest Labs' Saunders to Head Actavis When Deal Closes
8:55 a.m. May 14, 2014
- The Wall Street Journal Interactive Edition
Cross-Border Megamergers Drive Global Takeover Boom
4:01 p.m. May 12, 2014
- Investors Business Daily
3 Drugs Stocks On The Rise
1:02 p.m. May 12, 2014
- TheStreet.com
Actavis and Valeant settle patent fight
8:26 a.m. May 12, 2014
- Seeking Alpha
The 'Inversion' Premium
7:29 p.m. May 11, 2014
- The Wall Street Journal Interactive Edition
Vivus Discloses Competitive Threat
10:51 a.m. May 10, 2014
- Seeking Alpha
M.D. Sass: Bullish on Broadcast, Health Care
3:26 a.m. May 10, 2014
- Barrons.com
Acorda Misses on Earnings, Beats Revs - Analyst Blog
1:43 p.m. May 7, 2014
- Zacks.com
3 Drugs Stocks Dragging The Industry Down
1:03 p.m. May 7, 2014
- TheStreet.com
What Does Celgene's May 15 Markman Hearing Mean to You?
10:11 a.m. May 7, 2014
- TheStreet.com
Actavis, Michael Kors Among World Stocks Near Buy Points
5:50 p.m. May 6, 2014
- Investors Business Daily
10-Q: ACTAVIS PLC
5:15 p.m. May 5, 2014
- Edgar Online - (EDG = 10Q, 10K)
Hottest Healthcare Stocks Now – HMSY ACAD ACT MWIV
1:45 p.m. May 5, 2014
- InvestorPlace.com
Best Five Stocks Over $100
10:07 a.m. May 3, 2014
- 247WallSt.com
AstraZeneca Nixes New Bid As Pfizer Woos British PM
1:11 p.m. May 2, 2014
- Investors Business Daily
Earnings Beat at Endo, Shares Up on Improved Outlook - Analyst Blog
12:10 p.m. May 2, 2014
- Zacks.com
Actavis Extends Exclusive Agreement to Distribute Authorized Generic Concerta®
8:45 a.m. Today8:45 a.m. May 15, 2014
- PR Newswire - PRF
Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Forest Laboratories Acquisition
8:00 a.m. May 14, 2014
- PR Newswire - PRF
Agreements, Earnings Releases, Senior-Level Retirements and Appointments, and Marketing Authorizations - Analyst Notes on Actavis, Jazz Pharmaceuticals, Bristol-Myers, Biogen Idec and AbbVie
7:00 a.m. May 14, 2014
- PR Newswire - PRF
Actavis Receives Final Approval for Generic Version of Exalgo®
5:00 p.m. May 13, 2014
- PR Newswire - PRF
Actavis to Present at Sanford C. Bernstein Thirtieth Annual Strategic Decisions Conference 2014
4:45 p.m. May 13, 2014
- PR Newswire - PRF
Actavis Announces Acanya® Gel Patent Challenge Settlement
8:00 a.m. May 12, 2014
- PR Newswire - PRF
Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn
11:30 a.m. May 9, 2014
- PR Newswire - PRF
Actavis Launches Generic Version of Catapres-TTS®
4:05 p.m. May 7, 2014
- PR Newswire - PRF
Financial Results, Study Results, and Conference Schedules - Analyst Notes on Actavis, BMS, Baxter, Biogen Idec and AbbVie
9:00 a.m. May 6, 2014
- PR Newswire - PRF
Actavis and Forest Announce Effectiveness of Registration Statement
on Form S-4
9:02 a.m. May 5, 2014
- BusinessWire - BZX
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4
9:00 a.m. May 5, 2014
- PR Newswire - PRF
Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline
and Drop Tax Rate, an Industrial Info News Alert
6:31 a.m. April 30, 2014
- Marketwire
Stocks Close to Reporting their Earnings -- Research on Actavis, NYSE Community Bancorp, Hess, and Dominion Resources
4:36 a.m. April 30, 2014
- PR Newswire - PRF
Actavis Sues FDA Regarding Delay of Generic Celebrex® Approval
5:14 p.m. April 28, 2014
- PR Newswire - PRF
Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard
8:00 a.m. April 28, 2014
- PR Newswire - PRF
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts
8:00 a.m. April 25, 2014
- PR Newswire - PRF
Actavis Announces Celebrex® Patent Challenge Settlement
9:20 a.m. April 24, 2014
- PR Newswire - PRF
Actavis Announces Departure of G. Frederick Wilkinson, President, Actavis Global R&D
9:03 a.m. April 21, 2014
- PR Newswire - PRF
Actavis to Acquire Four Products from Akorn
4:15 p.m. April 17, 2014
- PR Newswire - PRF
Actavis and Forest Laboratories Receive FTC Second Request Under Hart-Scott-Rodino
4:05 p.m. April 17, 2014
- PR Newswire - PRF
(0)
(0)